APA (7th ed.) Citation

Masato Muraki, Kyuya Gose, Soichiro Hanada, Hirochiyo Sawaguchi, & Yuji Tohda. (2017). Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler? Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Masato Muraki, Kyuya Gose, Soichiro Hanada, Hirochiyo Sawaguchi, and Yuji Tohda. Which Inhaled Corticosteroid and Long-acting β-agonist Combination Is Better in Patients with Moderate-to-severe Asthma, a Dry Powder Inhaler or a Pressurized Metered-dose Inhaler? Taylor & Francis Group, 2017.

MLA (9th ed.) Citation

Masato Muraki, et al. Which Inhaled Corticosteroid and Long-acting β-agonist Combination Is Better in Patients with Moderate-to-severe Asthma, a Dry Powder Inhaler or a Pressurized Metered-dose Inhaler? Taylor & Francis Group, 2017.